Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF96.7.
  • Eventos
  • Noticias
  • Análisis
  • Cuenta
Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
Industry Events

News

Categories

  • Últimas
  • Agricultura
  • Cadena de Suministro
  • China y BRICS+
  • Ciberseguridad
  • Defensa
  • Energía y Movilidad
  • Fintech
  • IA y Tecnología
  • Robótica
  • Salud
  • Semiconductores
  • Startups y Capital Riesgo

Select a category to explore the latest industry reporting.

NewsWednesday, 26 August 2026
Newsletter subscribe · Free
  • Últimas
  • IA y Tecnología
  • Ciberseguridad
  • Semiconductores
  • Robótica
  • Fintech
  • Energía y Movilidad
  • Defensa
  • Salud
  • Cadena de Suministro
  • Startups y Capital Riesgo
  • China y BRICS+
  • Agricultura

Noticias

Salud

Las últimas noticias, anuncios y análisis del sector Salud, provenientes de las conferencias, exposiciones y cumbres que dan forma al sector.

Últimas noticias de la sección

Judge denies states’ motion to postpone Medicaid work requirement (opens original source in a new tab)
STAT News

Judge denies states’ motion to postpone Medicaid work requirement

Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

Federal judge denied 26 states’ request to postpone the implementation of Medicaid work requirements announced in June.

(opens original source in a new tab)
Anil Oza·30 July 2026
STAT+: Rising oil prices can boost the cost of some medicines. One expert says it’s time to lower reliance on fossil fuels (opens original source in a new tab)
STAT News

STAT+: Rising oil prices can boost the cost of some medicines. One expert says it’s time to lower reliance on fossil fuels

Unitaid found the rising price of oil could boost the cost of a widely used HIV medicine it reviewed in a detailed analysis.

(opens original source in a new tab)
Ed Silverman·30 July 2026
STAT+: Pharmalittle: We’re reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more (opens original source in a new tab)
STAT News

STAT+: Pharmalittle: We’re reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more

An FDA advisory panel concluded clinical data for a Capricor treatment for Duchenne muscular dystrophy did not provide “substantial evidence” of efficacy

(opens original source in a new tab)
Ed Silverman·30 July 2026
Ebola outbreak nears milestone, while a vaccine remains months away (opens original source in a new tab)
STAT News

Ebola outbreak nears milestone, while a vaccine remains months away

Medicaid work rules, FTC sues Hims, and more health news from Morning Rounds

(opens original source in a new tab)
Theresa Gaffney and Helen Branswell·30 July 2026
STAT+: FDA expert committee votes in favor of Replimune’s melanoma treatment (opens original source in a new tab)
STAT News

STAT+: FDA expert committee votes in favor of Replimune’s melanoma treatment

STAT is live-blogging a meeting of FDA experts to review Replimune’s experimental melanoma drug, RP1.

(opens original source in a new tab)
Matthew Herper and Elaine Chen·30 July 2026
Opinion: U.S. dependence on China is a national security risk (opens original source in a new tab)
STAT News

Opinion: U.S. dependence on China is a national security risk

“China is overtly seeking to displace U.S. leadership across the innovative biopharmaceutical value chain,” write authors of a Council on Foreign Relations report.

(opens original source in a new tab)
Prashant Yadav, Thomas J. Bollyky, Rush Doshi, Paul Friedrichs,and Victor Suarez·30 July 2026
Opinion: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases (opens original source in a new tab)
STAT News

Opinion: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases

“The next 10 years of mycetoma care will determine whether it remains a story of neglect or becomes one of collective action,” writes Borna Nyaoke-Anoke.

(opens original source in a new tab)
Borna Nyaoke-Anoke·30 July 2026
Chronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemption (opens original source in a new tab)
STAT News

Chronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemption

Patients, advocates, and experts fear the difficulty in documenting a frailty exemption to Medicaid work requirements will lead to millions losing coverage.

(opens original source in a new tab)
Isabella Cueto·30 July 2026
Is it safe to drink Red Bull and vodka? Questionable research tied to energy drink giant has shaped policy (opens original source in a new tab)
STAT News

Is it safe to drink Red Bull and vodka? Questionable research tied to energy drink giant has shaped policy

Studies tied to Red Bull helped block warning labels about drinking alcohol along with energy drinks. Independent studies report risks in mixing the two.

(opens original source in a new tab)
Sasha Chavkin, Ashley Okwuosa, Fernanda Aguirre Ruiz,and Romina Colman·30 July 2026
NSF testing new Ph.D. model giving trainees academic and industry experience (opens original source in a new tab)
STAT News

NSF testing new Ph.D. model giving trainees academic and industry experience

Students working in fields eligible for NSF funding will be able to participate, including chemistry, engineering, and basic life science research that doesn’t deal directly with the treatment of disease.

(opens original source in a new tab)
Jonathan Wosen·29 July 2026
STAT+: Latigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx (opens original source in a new tab)
STAT News

STAT+: Latigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx

Latigo Biotherapeutics published positive data for an acute-pain drug meant to rival a Vertex medicine already on the market

(opens original source in a new tab)
Jonathan Wosen·29 July 2026
STAT+: Hims misled consumers and violated their privacy, FTC alleges in a lawsuit (opens original source in a new tab)
STAT News

STAT+: Hims misled consumers and violated their privacy, FTC alleges in a lawsuit

The U.S. Federal Trade Commission sued telehealth company Hims & Hers alleging business practices that agency says misled consumers.

(opens original source in a new tab)
Katie Palmer·29 July 2026

Los más leídos

  1. 01

    Judge denies states’ motion to postpone Medicaid work requirement

  2. 02

    STAT+: Rising oil prices can boost the cost of some medicines. One expert says it’s time to lower reliance on fossil fuels

  3. 03

    STAT+: Pharmalittle: We’re reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more

  4. 04

    Ebola outbreak nears milestone, while a vaccine remains months away

  5. 05

    STAT+: FDA expert committee votes in favor of Replimune’s melanoma treatment

Prev
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
Next
  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF96.7.

La semana en eventos de la industria, entregada cada viernes.

Un email corto. Las mejores historias de ferias, conferencias y cumbres que dan forma a los negocios mundiales. Sin relleno, sin spam, cancela en cualquier momento.